🇺🇸 Esomeprazole Magnesium Enteric-coated Tablets in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 10

Most-reported reactions

1. Anaemia — 1 report (10%)
2. Coagulopathy — 1 report (10%)
3. Drug Eruption — 1 report (10%)
4. Hypoglobulinaemia — 1 report (10%)
5. Hypokalaemia — 1 report (10%)
6. Hypoproteinaemia — 1 report (10%)
7. Lymphocyte Count Decreased — 1 report (10%)
8. Myocardial Ischaemia — 1 report (10%)
9. Neutrophil Count Decreased — 1 report (10%)
10. Pain — 1 report (10%)

Source database →

Frequently asked questions

Is Esomeprazole Magnesium Enteric-coated Tablets approved in United States?

Esomeprazole Magnesium Enteric-coated Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Esomeprazole Magnesium Enteric-coated Tablets in United States?

Fifth Affiliated Hospital, Sun Yat-Sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.